August 16th, 2013

Abbott Labs Accused of Racketeering in Depakote Marketing Suit

By Andrew Harris
Bloomberg Businessweek

Abbott Laboratories (ABT:US) allegedly engaged in racketeering when it led an effort to market the epilepsy drug Depakote for unapproved uses, according to a federal court complaint filed in Chicago.
The pharmaceutical company last year agreed to pay $1.6 billion to settle state and federal claims it promoted the drug’s use to treat bi-polar mania and to prevent migraine headaches.

Read more:


Add your own Comment